S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
S&P 500   0.63 (+2.44%)
DOW   0.63 (+2.44%)
BA   187.94 (+4.43%)
Log in

NASDAQ:DAREDare Bioscience Stock Price, Forecast & News

$1.26
-0.26 (-17.11 %)
(As of 07/15/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.15
Now: $1.26
$1.50
50-Day Range
$0.99
MA: $1.03
$1.52
52-Week Range
$0.69
Now: $1.26
$2.22
Volume5.30 million shs
Average Volume1.41 million shs
Market Capitalization$33.58 million
P/E RatioN/A
Dividend YieldN/A
Beta1.82
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing women's reproductive health products in the United States. The company intends to develop therapies in the areas of contraception, vaginal health, sexual health, and fertility. Its product candidates include Ovaprene, a non-hormonal monthly contraceptive; and SST-6007, a topical sildenafil cream for female sexual arousal disorder. The company has license and collaboration agreement with Strategic Science and Technologies-D, LLC and Strategic Science Technologies, LLC to develop and commercialize indications for women related to female sexual dysfunction and/or female reproductive health. The company was incorporated in 2005 and is headquartered in San Diego, California.
Read More
Dare Bioscience logo

Beat the Market (BTM) Rank

Analyst Opinion: 4.4Community Rank: 2.9Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.59 out of 5 stars


Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:DARE
CUSIPN/A
Phone858-926-7655

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A
Book Value$0.02 per share

Profitability

Net Income$-14,260,000.00

Miscellaneous

Employees5
Market Cap$33.58 million
Next Earnings Date8/12/2020 (Estimated)
OptionableNot Optionable

Receive DARE News and Ratings via Email

Sign-up to receive the latest news and ratings for DARE and its competitors with MarketBeat's FREE daily newsletter.

Dare Bioscience (NASDAQ:DARE) Frequently Asked Questions

How has Dare Bioscience's stock been impacted by COVID-19 (Coronavirus)?

Dare Bioscience's stock was trading at $1.01 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, DARE stock has increased by 24.8% and is now trading at $1.26. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Dare Bioscience?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Dare Bioscience in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Dare Bioscience.

When is Dare Bioscience's next earnings date?

Dare Bioscience is scheduled to release its next quarterly earnings announcement on Wednesday, August 12th 2020. View our earnings forecast for Dare Bioscience.

How were Dare Bioscience's earnings last quarter?

Dare Bioscience Inc (NASDAQ:DARE) issued its quarterly earnings data on Thursday, May, 14th. The biotechnology company reported ($0.18) EPS for the quarter, beating the Thomson Reuters' consensus estimate of ($0.34) by $0.16. View Dare Bioscience's earnings history.

What price target have analysts set for DARE?

5 equities research analysts have issued 1-year price targets for Dare Bioscience's shares. Their forecasts range from $3.00 to $7.50. On average, they anticipate Dare Bioscience's stock price to reach $4.50 in the next twelve months. This suggests a possible upside of 257.1% from the stock's current price. View analysts' price targets for Dare Bioscience.

Has Dare Bioscience been receiving favorable news coverage?

News coverage about DARE stock has trended somewhat positive recently, InfoTrie Sentiment Analysis reports. InfoTrie identifies positive and negative press coverage by monitoring more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of -5 to 5, with scores closest to five being the most favorable. Dare Bioscience earned a news sentiment score of 1.0 on InfoTrie's scale. They also assigned news headlines about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the immediate future. View the latest news about Dare Bioscience.

Who are some of Dare Bioscience's key competitors?

What other stocks do shareholders of Dare Bioscience own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Dare Bioscience investors own include FuelCell Energy (FCEL), Gilead Sciences (GILD), Inovio Pharmaceuticals (INO), Novavax (NVAX), Tonix Pharmaceuticals (TNXP), VBI Vaccines (VBIV), Vaxart (VXRT), SCYNEXIS (SCYX), Ocular Therapeutix (OCUL) and Verastem (VSTM).

Who are Dare Bioscience's key executives?

Dare Bioscience's management team includes the following people:
  • Ms. Sabrina Martucci Johnson, Pres, CEO, Sec. & Director (Age 52)
  • Ms. Lisa Walters-Hoffert, Chief Financial Officer (Age 60)
  • Mr. Mark Walters, VP of Operations (Age 64)
  • Ms. MarDee J. Haring-Layton, VP of Accounting & Fin. (Age 43)
  • Dr. David Friend, Chief Scientific Officer

What is Dare Bioscience's stock symbol?

Dare Bioscience trades on the NASDAQ under the ticker symbol "DARE."

How do I buy shares of Dare Bioscience?

Shares of DARE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Dare Bioscience's stock price today?

One share of DARE stock can currently be purchased for approximately $1.26.

How big of a company is Dare Bioscience?

Dare Bioscience has a market capitalization of $33.58 million. The biotechnology company earns $-14,260,000.00 in net income (profit) each year or ($0.97) on an earnings per share basis. Dare Bioscience employs 5 workers across the globe.

What is Dare Bioscience's official website?

The official website for Dare Bioscience is www.darebioscience.com.

How can I contact Dare Bioscience?

Dare Bioscience's mailing address is 3655 NOBEL DRIVE SUITE 260, SAN DIEGO CA, 92122. The biotechnology company can be reached via phone at 858-926-7655 or via email at [email protected]

This page was last updated on 7/15/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.